Petricca, L., Gigante, M. R., Paglionico, A., Costanzi, S., Vischini, G., Di Mario, C., . . . Gremese, E. (2020). Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies. Front Med (Lausanne).
Citação norma ChicagoPetricca, Luca, et al. "Rituximab Followed By Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies." Front Med (Lausanne) 2020.
Citação norma MLAPetricca, Luca, et al. "Rituximab Followed By Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies." Front Med (Lausanne) 2020.